Aclaris Therapeutics, Inc. (ACRS) vs CytomX Therapeutics, Inc. (CTMX)
A side-by-side comparison of Aclaris Therapeutics, Inc. and CytomX Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACRS
Aclaris Therapeutics, Inc.
$3.68HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
CTMX
CytomX Therapeutics, Inc.
$2.56HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — ACRS vs CTMX
growth of $100 · dividends reinvested · last 10yACRS -83.0% (-16.2%/yr)CTMX -83.3% (-16.4%/yr)ACRS compounded faster over this window
ACRS CTMX
ACRS vs CTMX: by the numbers
- •CTMX is the larger company ($557M vs $514M market cap).
- •Both run net losses; CTMX's is the smaller (-435.21% vs -921.50% net margin).
- •ACRS grew revenue faster over the past five years (4.39% vs 2.18% CAGR).
Metrics side by side
Valuation
| Metric | ACRS | CTMX |
|---|---|---|
| P/S ratio | 62.51 | 30.42 |
| P/B ratio | 4.12 | 1.84 |
Profitability
| Metric | ACRS | CTMX |
|---|---|---|
| Gross margin | 73.28% | 98.63% |
| Operating margin | -975.91% | -29.35% |
| Net margin | -921.50% | -435.21% |
| ROE | -60.79% | -26.37% |
| ROIC | -56.99% | -25.42% |
Growth (annualized)
| Metric | ACRS | CTMX |
|---|---|---|
| Revenue CAGR (5Y) | 4.39% | 2.18% |
| Total return CAGR (5Y) | -24.23% | -12.01% |
Frequently asked
- Which has grown faster, ACRS or CTMX?
- Over the past five years, ACRS grew revenue faster — ACRS at a 4.39% CAGR versus CTMX at 2.18%.
- How have ACRS and CTMX total returns compared?
- Over the past 10 years, ACRS delivered -16.23% and CTMX delivered -16.62% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.